Research ExplorerScientific StaffMartin Lambert Publications

Prof. Dr. med. ID: 57412

Martin Lambert

Group leader

graph of relations
Affiliations
Emails
Phone: 0049-40-7410-24041Fax: 0049-40-7410-52999
451 - 496 out of 496Page size: 50

Publications

  1. 2000

  2. Psychosocial aspects of psychotic patients from turkey.

    Haasen, C., Yagdiran, O., Lambert, M. & Maß, R., 2000, Psychosocial care in a migration society.. Koch, E., Schepker, R. & Taneli, S. (eds.). Lambertus-Publisher, p. 187-200

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  3. Quality of life of schizophrenic patients under atypical antipsychotic treatment.

    Karow, A., Moritz, S., Lambert, M., Krausz, M. & Naber, D., 2000, Psychiatry und Psychotherapy.. Bullinger, M., Siegrist, J. & Ravens-Sieberer, U. (eds.). Hogrefe, p. 74-85

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  4. Relationship of substance abuse disorders and suicidality in paranoid schizophrenic patients.

    Lambert, M., Haasen, C., Maß, R., Wagner, H. B., Moritz, S., Krausz, M. & Naber, D., 2000, In: NERVENHEILKUNDE. 19, p. 69-75

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Treatment resistance in schizophrenic patients - actual standards.

    Lambert, M., Moritz, S., Bender, S., Krausz, M. & Naber, D., 2000, In: PSYCHOPHARMAKOTHERAP. 8, p. 2-17

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  6. 1999

  7. Chancen neuer Therapien schizophrener Patienten am Beispiel moderner Antipsychotika

    Lambert, M., Naber, D., Perro, C., Moritz, S. & Krausz, M., 04.1999, In: PSYCHIAT PRAX. 26 Suppl 1, p. S30-5

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

  8. Das Konstrukt Lebensqualität. Metaanalytische Validierung und die Entwicklung eines modularen Erhebungssystems

    Pukrop, R., Möller, H. J., Sass, H., Sauer, H., Klosterkötter, J., Czernik, A., Krausz, M., Stieglitz, R. D., Lambert, M., Matthies, H., Schaub, A., Woschnik, M., Wulfinghoff, F. & Steinmeyer, E. M., 01.1999, In: NERVENARZT. 70, 1, p. 41-53 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. [Admission status of alcohol and drug-dependent patients in "high threshold" access to withdrawal treatment]

    Wagner, H. B., Schwoon, D., Lambert, M. & Krausz, M., 1999, In: PSYCHIAT PRAX. 26, 1, p. 25-28 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Amisulpride - an atypical antipsychotic in the treatment of schizophrenia.

    Lambert, M. & Naber, D., 1999, In: Fundamenta Psychiatrica. 13, p. 43-70

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  11. Atypical Antipsychotics: compliance and quality of life.

    Naber, D. & Lambert, M., 1999, Atypical antipsychotics in the treatment of schizophrenic patients. Möller, HJ. & Müller, N. (eds.). Steinkopff-Publisher, p. 1-16

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  12. Atypical neuroleptics - a new area in the treatment of schizophrenic patients?

    Lambert, M., 1999, In: Psychosoziale Umschau. 1, p. 28-29

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  13. Atypical neuroleptics in the treatment of schizophrenic patients.

    Naber, D., Lambert, M. & Krausz, M., 1999, Uni-Med. 178 p.

    Research output: Book/anthology › Collected edition/anthology › Research

  14. Cannabis.

    Krausz, M. & Lambert, M., 1999, Addiction medicine - concepts, strategies and therapeutical interventions. Uchtenhagen, A. & Ziegelgänsberger, G. (eds.). Urban & Fischer, p. 77-82

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  15. Consequences of language problems in inpatients Treatment of immigrants.

    Haasen, C., Kraft, M., Yagdiran, O., Maß, R., Lambert, M., Müller-Thomsen, T. & Krausz, M., 1999, In: Krankenhauspsychiatrie. 10, p. 91-95

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Could atypical antipsychotics improve rehabilitation of schizophrenic patients?

    Perro, C., Lambert, M. & Naber, D., 1999, In: Gfts-Journal. 14, p. 18-22

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  17. Language effect on assessment of psychopathology.

    Haasen, C., Yagdiran, O., Lambert, M. & Krausz, M., 1999, In: CURR OPIN PSYCHIATR. 12, p. 11-24

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Langzeitbehandlung der Schizophrenie.

    Lambert, M., 1999, Atypische Neuroleptika in der Behandlung schizophrener Patienten. Naber, D., Lambert, M. & Krausz, M. (eds.). Uni-Med, p. 71-75

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  19. Neurocognitive alterations in the treatment of schizophrenic patients with clozapine.

    Moritz, S., Naber, D., Krausz, M., Lambert, M. & Andresen, B., 1999, Clozapine - pharmacology and clinical issues of an atypical antipsychotic. Naber, D. & Müller-Spahn, F. (eds.). Berlin Heidelberg New York: Springer, p. 90-108

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  20. Neuroleptic-induced extrapyramidal symptoms are accompanied by cognitive dysfunction in schizophrenia.

    Krausz, M., Moritz, S., Naber, D., Lambert, M. & Andresen, B., 1999, In: EUR PSYCHIAT. 14, 2, p. 84-88 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Neuroleptische Nebenwirkungen und deren Behandlung.

    Lambert, M., 1999, Atypische Neuroleptika in der Behandlung schizophrener Patienten. Naber, D., Lambert, M. & Krausz, M. (eds.). Uni-Med, p. 54-68

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  22. Nichtpharmakologische Behandlungsansätze in der Schizophrenietherapie.

    Lambert, M., 1999, Atypische Neuroleptika in der Behandlung schizophrener Patienten. Naber, D., Lambert, M. & Krausz, M. (eds.). Uni-Med, p. 98-120

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  23. Olanzapine - an atypical antipsychotic in the treatment of schizophrenia.

    Lambert, M., Perro, C., Holzbach, R., Krausz, M. & Naber, D., 1999, In: PSYCHOPHARMAKOTHERAP. 2, p. 38-52

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  24. Optimising treatment of schizophrenic patients with atypical neuroleptics.

    Lambert, M., Moritz, S. & Naber, D., 1999, In: PSYCHOPHARMAKOTHERAP. 3, p. 42-54

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  25. Pharmacotherapy of schizophrenia spectrum disorders in a dayclinicl setting.

    Lambert, M., Stark, M., Krausz, M. & Naber, D., 1999, Dayclinical treatment. Eikelmann, B. (ed.). Georg Thieme Verlag KG, p. 83-96

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  26. Pharmacotherapy of schizophrenia spectrum disorders - the actual state.

    Lambert, M., Haasen, C. & Naber, D., 1999, Schizophrenia - ways of treatment. Hartwich, P. & Pflug, B. (eds.). Publisher Wissenschaft & Praxis, p. 95-122

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  27. Pharmakokinetik atypischer Neuroleptika.

    Lambert, M., 1999, Atypische Neuroleptika in der Behandlung schizophrener Patienten. Naber, D., Lambert, M. & Krausz, M. (eds.). Uni-Med, p. 30-36

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  28. Pharmakologie atypischer Neuroleptika.

    Lambert, M., 1999, Atypische Neuroleptika in der Behandlung schizophrener Patienten. Naber, D., Lambert, M. & Krausz, M. (eds.). Uni-Med, p. 18-27

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  29. Pharmakotherapie ersterkrankter schizophrener Patienten.

    Lambert, M., 1999, Atypische Neuroleptika in der Behandlung schizophrener Patienten. Naber, D., Lambert, M. & Krausz, M. (eds.). Uni-Med, p. 69-71

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  30. Psychiatric disorders of immigrants in the clinical setting.

    Lambert, M., Haasen, C., Yagdiran, O. & Krausz, M., 1999, In: Krankenhauspsychiatrie. 2, p. 49-53

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  31. Psychological disorders as risk factor for addictive behaviour.

    Krausz, M. & Lambert, M., 1999, Addiction medicine - concepts, strategies and therapeutical interventions. Uchtenhagen, A. & Ziegelgänsberger, G. (eds.). Urban & Fischer, p. 206-211

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  32. Psychopharmacological treatment of the first acute schizophrenic episode schould consist of atypical neuroleptics.

    Naber, D., Krausz, M. & Lambert, M., 1999, In: Belgian Consensus Conference on the Treatment of Schizophrenia. 12, p. 76-94

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  33. Psychopharmakotherapie der akuten Schizophrenie.

    Lambert, M., 1999, Atypische Neuroleptika in der Behandlung schizophrener Patienten. Naber, D., Lambert, M. & Krausz, M. (eds.). Uni-Med, p. 41-50

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  34. [Quality of life. Construct validation and the development of a modular system]

    Pukrop, R., Möller, H. J., Sass, H., Sauer, H., Klosterkötter, J., Czernik, A., Krausz, M., Stieglitz, R. D., Lambert, M., Matthies, H., Schaub, A., Woschnik, M., Wulfinghoff, F. & Steinmeyer, E. M., 1999, In: NERVENARZT. 70, 1, p. 41-53 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Refractory Schizophrenia.

    Naber, D., Krausz, M., Lambert, M. & Bender, S., 1999, Difficult clinical problems in psychiatry. Lader, M. & Naber, D. (eds.). Martin Dunitz Publishers, p. 3-22

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  36. Reviews der atypischen Neuroleptika Zotepin, Risperidon, Olanzapin, Clozapin, Sertindol, Quetiapin, Ziprasidon und Amisulprid.

    Lambert, M., 1999, Atypische Neuroleptika in der Behandlung schizophrener Patienten. Naber, D., Lambert, M. & Krausz, M. (eds.). Uni-Med, p. 121-177

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  37. Sertindole decreases hospitalisation and improves the quality of life of schizophrenic patients.

    Naber, D. & Lambert, M., 1999, In: INT J PSYCHIAT CLIN. 2, p. 73-77

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  38. Spezielle Aspekte der Langzeitbehandlung.

    Lambert, M., 1999, Atypische Neuroleptika in der Behandlung schizophrener Patienten. Naber, D., Lambert, M. & Krausz, M. (eds.). Uni-Med, p. 78-97

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  39. Stimulus onset asynchronicity as a Modulator of negative priming in schizotypy.

    Moritz, S., Andresen, B., Probsthein, E., Martin, T., Domin, F., Kretschmar, G., Krausz, M., Lambert, M. & Naber, D., 1999, In: PERS INDIV DIFFER. 3, p. 1-9

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. [Success of new treatments for schizophrenics, as shown by the example of modern antipsychotic drugs]

    Lambert, M., Naber, D., Perro, C., Moritz, S. & Krausz, M., 1999, In: PSYCHIAT PRAX. 26, 1, p. 30-35 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. 1998

  42. Differential diagnosis of psychotic disorders in immigrants.

    Lambert, M., Haasen, C. & Halilovic, H., 1998, In: PSYCHIAT PRAX. 25, p. 198-9

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Impact of ethnicity on the prevalence of psychiatric disorders among migrants in Germany.

    Haasen, C., Lambert, M., Mass, R. & Krausz, M., 1998, In: ETHNIC HEALTH. 3, 3, p. 159-165 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Psychotic disorders in migrants: empirical results and case-reports.

    Yagdiran, O., Haasen, C., Lambert, M., Schröder, J. & Krausz, M., 1998, In: Psycho. 25, p. 198-9

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. 1997

  46. Konsummuster und Konsummotivation des Suchtmittelgebrauchs bei schizophrenen Patienten

    Lambert, M., Haasen, C., Mass, R. & Krausz, M., 07.1997, In: PSYCHIAT PRAX. 24, 4, p. 185-9 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. [Consumption patterns and motivation for use of addictive drugs in schizophrenic patients]

    Lambert, M., Haasen, C., Mass, R. & Krausz, M., 1997, In: PSYCHIAT PRAX. 24, 4, p. 185-189 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Diagnostic aspects of psychiatric disorders among migrants.

    Haasen, C., Lambert, M. & Yagdiran, O., 1997, In: Curare. 19, p. 347-352

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  49. Influence of addictive behaviour on psychopathology in paranoid schizophrenia.

    Krausz, M., Lambert, M., Haasen, C. & Mac, R., 1997, In: Krankenhauspsychiatrie. 8, p. 104-110

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. Psychiatric disorders among migrants in Germany: prevalence in a psychiatric clinic and implications for services and research.

    Haasen, C., Lambert, M., Yagdiran, O. & Krausz, M., 1997, In: EUR PSYCHIAT. 12, p. 305-310

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1...6 7 8 9 10 Next